Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Roche Innovation Center Shanghai (RICS), formerly known as the Roche R&D Center (China), is a major research and development hub for Roche located in the Zhangjiang Hi-Tech Park. Established in 2004, it was the first R&D center in China wholly owned by a multinational pharmaceutical company. The center focuses on the discovery and development of innovative medicines, particularly in the fields of infectious diseases, immunology, and oncology. RICS plays a critical role in Roche's global R&D network, leading programs from early discovery through clinical proof-of-concept, with a specific emphasis on addressing unmet medical needs in China and globally, such as Chronic Hepatitis B.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Biotechnology China Research Center.